Global /China /Basic Materials /Specialty Chemicals /301281

Shandong Keyuan Pharmaceutical Co., Ltd.

301281

• SHE: 301281 • Delayed

37.69CNY -0.5%

5.57 USD

As of 14 June 2026, Shandong Keyuan Pharmaceutical Co., Ltd. has a market cap of $605.54M USD, ranking #13903 globally and #4263 in China. It ranks #1438 in the Basic Materials sector, and #473 in the Specialty Chemicals industry.

Global Rank

13903

Country Rank

4263

Sector Rank

1438

Industry Rank

473

Key Stats

Market Cap

$605.54MUSD

4.1B CNY

Enterprise Value

$575.88MUSD

3.9B CNY

Revenue (TTM)

$66.16MUSD

448.33M CNY

EBITDA (TTM)

$12.39MUSD

83.83M CNY

Net Income (TTM)

$3.47MUSD

23.54M CNY

EBITDA Margin

19%

Profit Margin

5.3%

PE Ratio

177.6

PS Ratio

9.2

PB Ratio

2.9

EV/EBITDA

33.3

Company Profile

Country (HQ)

China

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Chun Po Gao open_in_new

Employees

696

Founded

2004

Website

keyuanpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.5%	-3.3%	-3.3%	18%	20%	29%	27%	40%	59%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301281 山东科源制药股份有限公司 Class A ISIN: CNE1000061V8 Shares Out.: Shares Outstanding: 25.691M¹ TV: TradingView: SZSE: 301281 SA: Stock Analysis: SHE: 301281 YF: Yahoo Finance: 301281.SZ GF: Google Finance: SHE: 301281 BA: Barron's: 301281 MS: Morningstar: XSHE: 301281	37.69 CNY	TV: TradingView: SZSE: 301281 SA: Stock Analysis: SHE: 301281 YF: Yahoo Finance: 301281.SZ GF: Google Finance: SHE: 301281 BA: Barron's: 301281 MS: Morningstar: XSHE: 301281

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shandong Keyuan Pharmaceutical Co., Ltd.

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride. The company was founded in 2004 and is headquartered in Jinan, China.

Similar Companies

Industry: Specialty Chemicals (China)

Name	Market Cap (USD) diff.	PE	Country
Wanhua Chemical Group Co., Ltd. SSE: 600309	$41.37B 280.3B CNY 7K%	21.3	China
Ningxia Baofeng Energy Group Co., Ltd. SSE: 600989	$33.41B 226.4B CNY 5K%	18.0	China
China Northern Rare Earth (Group) High-Tech Co.,Ltd SSE: 600111	$27.18B 184.19B CNY 4K%	67.3	China
Ganfeng Lithium Group Co., Ltd. SHE: 002460	$25.74B 174.39B CNY 4K%	47.3	China
Hengli Petrochemical Co.,Ltd. SSE: 600346	$23.08B 156.41B CNY 4K%	17.4	China
China Jushi Co., Ltd. SSE: 600176	$20.91B 141.68B CNY 3K%	37.3	China

Industry: Specialty Chemicals (Global)

Name	Market Cap (USD) diff.	PE	Country
Linde plc NASDAQ: LIN	$233.88B 39K%	34.5	United Kingdom
Air Liquide S.A. EPA: AI	$121.12B 104.79B EUR 20K%	29.9	France
Shin-Etsu Chemical Co., Ltd. TSE: 4063	$82.13B 13.15T JPY 13K%	28.0	Japan
The Sherwin-Williams Co. NYSE: SHW	$77.94B 13K%	30.5	United States
Ecolab Inc. NYSE: ECL	$72.47B 12K%	34.7	United States
Air Products and Chemicals, Inc. NYSE: APD	$67.35B 11K%	-	United States

chevron_leftBack